Feline fibrosarcomas in vaccination sites

Feline Practice

Volumn 26, Issue 5, 1998, Pages 18-20

  Baker, Rachele J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22444455270     PISSN: 10576614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kass PH, Barnes WG, Spangler WL, Chomel BB, Culbertson MR: Epidemiologic Evidence for a Causal Relation Between Vaccination and Fibrosarcoma Tumorigenesis in Cats. JAVMA 203:396-405, 1993.
2. Hendrick MJ, Shofer FS, Goldschmidt MH, et al: Comparison of Fibrosarcomas That Developed at Vaccination Sites and at Nonvaccination Sites in Cats: 239 Cases (1991-1992). JAVMA 205:1425-1429, 1994.
3. Hendrick MJ, Goldschmidt MH, Shofer FS, et al: Postvaccinal Sarcomas in the Cat: Epidemiology and Electron Probe Microanalytical Identification of Aluminum. Cancer Research 52: 5391-5394, 1992.
4. Doddy FD, Glickman LT, Glickman NW, Janovitz, EB: Feline Fibrosarcomas at Vaccination Sites and Non-vaccination Sites. J Comp Pathol 114:165-174, 1996.
5. Macy DW, Hendrick MJ: The Potential Role of Inflammation in the Development of Postvaccinal Sarcomas in Cats. The Veterinary Clinics of North America Small Animal Practice Controversies in Clinical Oncology 26:103-109, 1996.
6. Ellis JA, Jackson ML, Bartsch RC, et al: Use of Immunohistochemistry and Polymerase Chain Reaction for Detection of Oncornaviruses in Formalin-fixed, Paraffin-embedded Fibrosarcomas From Cats. JAVMA 209:767-771, 1996.
7. Theilen GH, Madewell BR: Veterinary Cancer Medicine, ed 2. Philadelphia, Lea & Febiger, 1987, pp 147, 382-385.
8. Hendrick MJ, Brooks JJ: Postvaccinal Sarcomas in the Cat: Histology and Immunohistochemistry. Veterinary Pathol 31:126-129, 1994.
9. Hendrick MJ, Kass PH, McGill LD, et al: Postvaccinal Sarcomas in Cats. J National Cancer Institute 86:341-343, 1994.
10. Esplin DG, McGill LD, Meininger AC, et al: Postvaccination Sarcomas in Cats. JAVMA 202:1245-1247, 1993.
11. Martins-Green M, Boudreau N, Bissell MJ: Inflammation is Responsible for the Development of Wound-induced Tumors in Chickens Infected With Rous Sarcoma Virus. Cancer Res 54:4334-4341, 1994.
12. Smith CA: Current Concepts: Are We Vaccinating Too Much? JAVMA 207:421-425. 1995.
13. Dayan AD: Safety Evaluation of Biological and Biotechnology-derived Medicines. Toxicology 105:59-68, 1995.
14. Donawho CK, Muller HK, Bucana CD, et al: Enhanced Growth of Murine Melanoma in Ultraviolet-irradiated Skin Is Associated With Local Inhibition of Immune Effector Mechanisms. J Immunol 157:781-786, 1996.
15. Mayr B, Schaffner G, Kurzbauer R. et al: Mutations in Tumour Suppressor Gene p53 in Two Feline Fibrosarcomas. Brit Vet J 151:707-713, 1995.
16. Greenblatt MS, Bennett WP, Hollstein M, et al: Mutations in the p53 Tumor Suppressor Gene: Clues to Cancer Etiology and Molecular Pathogenesis. Cancer Res 54:4855-4878, 1994.
17. Velculescu VE, El-Deiry WS: Biological and Clinical Importance of the p53 Tumor Suppressor Gene. Clinical Chemistry 42:858-868, 1996.
18. Alberts B, Bray D, Lewis J, et al: Molecular Biology of the Cell, ed 3. New York, Garland Publishing, Inc, 1994, p 1285.
19. Hanawalt PC: Role of Transcription-coupled DNA Repair in Susceptibility of Environmental Carcinogenesis. Environmental Health Perspectives Supplements 104:547-551, 1996.
20. AVMA/VAFSTF Web Site: http://www.avma.org/vafstf/default.htm, 1998.
21. Richards JR: Concerns Facing the Profession: Feline Sarcoma Task Force Meets. JAVMA 210:310-311, 1997.
22. U.S. Pharmacopeia Web Site: http://www.usp.org/prn/vprp.htm, 1998.
23. Meyer EK, DVM, US Pharmacopeia Veterinary Practitioners' Reporting Program, Rockville, MD. Personal Communication September 16, 1996.
24. Withrow SJ, MacEwen EG: Small Animal Clinical Oncology, ed 2 Philadelphia, WB Saunders Company, 1996, pp 151-152, 211-226.
25. Ogilvie GK, Moore AS: Managing the Veterinary Cancer Patient: A Practice Manual. Trenton, Veterinary Learning Systems Co, Inc, 1995, pp 515-518.